title: Infectious etiologies in acute exacerbation of COPD.
abstract: Acute exacerbation (AE) is a frequent episode during the prolonged chronic course of chronic obstructive pulmonary disease (COPD), which entails significant morbidity and mortality. The purpose of this study was to determine the frequency distribution of infectious etiologies in these episodes. Two hundred forty hospitalizations for AECOPD were included in a prospective, purely serologically based study. Paired sera were obtained for each of the hospitalizations and were tested using immunofluorescence or EIA methods to identify 13 different pathogens. Only significant changes in antibody titers were considered diagnostic. The mean age ( +/- SD) of the patients was 66.8 +/- 9.0 years and 179 (84%) were males. In 175 (72.9%) hospitalizations at least one infectious etiology was identified. In 117 (48.8%) hospitalizations at least one of 7 viral etiologies was identified. In 72 (30.0%) hospitalizations at least one of the following atypical bacteria was identified: Legionella spp. in 40 (16.7%), Mycoplasma pneumoniae in 34 (14.2%), and Coxiella burnetii in a single hospitalization. In 58 (24.2%) hospitalizations at least one classic bacterial etiology was found: Streptococcus pneumoniae in 48 (20.0%), Hemophilus influenzae in 10 (4.2%) and Moraxella catarrhalis in 9 (3.8%). More than one etiology was found in 72 (30.0%) hospitalizations. There were no significant differences in the etiologic distribution when the patients were classified by severity of airway obstruction or the clinical type of the exacerbation. We conclude that in most cases of hospitalization due to AECOPD the infectious etiology is viral or atypical bacteria and is classic bacteria in only a minority of cases. More than one etiologic cause can be identified in a third of the cases. The frequency distribution of the etiologies is not associated with the severity of airway obstruction or the clinical type of the exacerbation. The results of our study suggest that atypical bacteria should be covered in antibiotic regimens recommended for AECOPD. This issue should be addressed in future studies.
authors.affiliation: Pulmonary Unit and Division of Internal Medicine, Soroka Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Lieberma@bgumail.bgu.ac.il
authors.forename: D
authors.initials: D
authors.lastname: Lieberman
authors.forename: D
authors.initials: D
authors.lastname: Lieberman
authors.forename: M
authors.initials: M
authors.lastname: Ben-Yaakov
authors.forename: Z
authors.initials: Z
authors.lastname: Lazarovich
authors.forename: S
authors.initials: S
authors.lastname: Hoffman
authors.forename: B
authors.initials: B
authors.lastname: Ohana
authors.forename: M G
authors.initials: MG
authors.lastname: Friedman
authors.forename: B
authors.initials: B
authors.lastname: Dvoskin
authors.forename: M
authors.initials: M
authors.lastname: Leinonen
authors.forename: I
authors.initials: I
authors.lastname: Boldur
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006760:Hospitalization; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000276:immunology / Q000382:microbiology* / Q000821:virology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies